Literature DB >> 11731782

Neural progenitors from human embryonic stem cells.

B E Reubinoff1, P Itsykson, T Turetsky, M F Pera, E Reinhartz, A Itzik, T Ben-Hur.   

Abstract

The derivation of neural progenitor cells from human embryonic stem (ES) cells is of value both in the study of early human neurogenesis and in the creation of an unlimited source of donor cells for neural transplantation therapy. Here we report the generation of enriched and expandable preparations of proliferating neural progenitors from human ES cells. The neural progenitors could differentiate in vitro into the three neural lineages--astrocytes, oligodendrocytes, and mature neurons. When human neural progenitors were transplanted into the ventricles of newborn mouse brains, they incorporated in large numbers into the host brain parenchyma, demonstrated widespread distribution, and differentiated into progeny of the three neural lineages. The transplanted cells migrated along established brain migratory tracks in the host brain and differentiated in a region-specific manner, indicating that they could respond to local cues and participate in the processes of host brain development. Our observations set the stage for future developments that may allow the use of human ES cells for the treatment of neurological disorders.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11731782     DOI: 10.1038/nbt1201-1134

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  261 in total

1.  Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons.

Authors:  Sangmi Chung; Kai-C Sonntag; Therese Andersson; Lars M Bjorklund; Jae-Joon Park; Dong-Wook Kim; Un Jung Kang; Ole Isacson; Kwang-Soo Kim
Journal:  Eur J Neurosci       Date:  2002-11       Impact factor: 3.386

Review 2.  A systematic review of the effects of pharmacological agents on walking function in people with spinal cord injury.

Authors:  Antoinette Domingo; Abdulaziz A Al-Yahya; Yousif Asiri; Janice J Eng; Tania Lam
Journal:  J Neurotrauma       Date:  2012-02-29       Impact factor: 5.269

Review 3.  Using human pluripotent stem cells to untangle neurodegenerative disease mechanisms.

Authors:  Brigitte Malgrange; Laurence Borgs; Benjamin Grobarczyk; Audrey Purnelle; Patricia Ernst; Gustave Moonen; Laurent Nguyen
Journal:  Cell Mol Life Sci       Date:  2010-10-26       Impact factor: 9.261

Review 4.  Embryonic stem cells.

Authors:  H J Rippon; A E Bishop
Journal:  Cell Prolif       Date:  2004-02       Impact factor: 6.831

5.  Clonal neural stem cells from human embryonic stem cell colonies.

Authors:  Radha Chaddah; Margot Arntfield; Susan Runciman; Laura Clarke; Derek van der Kooy
Journal:  J Neurosci       Date:  2012-06-06       Impact factor: 6.167

Review 6.  Stem cell-based models and therapies for neurodegenerative diseases.

Authors:  Shilpa Iyer; Khaled Alsayegh; Sheena Abraham; Raj R Rao
Journal:  Crit Rev Biomed Eng       Date:  2009

Review 7.  In vivo imaging of embryonic stem cell therapy.

Authors:  Han Jiang; Zhen Cheng; Mei Tian; Hong Zhang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-11-24       Impact factor: 9.236

8.  FGF inhibition directs BMP4-mediated differentiation of human embryonic stem cells to syncytiotrophoblast.

Authors:  Smita Sudheer; Raghu Bhushan; Beatrix Fauler; Hans Lehrach; James Adjaye
Journal:  Stem Cells Dev       Date:  2012-08-06       Impact factor: 3.272

Review 9.  Challenges for stem cells to functionally repair the damaged auditory nerve.

Authors:  Karina Needham; Ricki L Minter; Robert K Shepherd; Bryony A Nayagam
Journal:  Expert Opin Biol Ther       Date:  2012-10-25       Impact factor: 4.388

Review 10.  Pluripotent stem cells in regenerative medicine: challenges and recent progress.

Authors:  Viviane Tabar; Lorenz Studer
Journal:  Nat Rev Genet       Date:  2014-02       Impact factor: 53.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.